Cambrex och AstraZeneca

We are pleased to have Cambrex and AstraZeneca as industrial partners, contributing valuable expertise to Mistra SafeChem. We asked them about their expectations and contributions.

Cambrex provides industrial insight and large-scale expertise

Päivi Tolstoy is Manager Process Development at Cambrex.

Why did Cambrex decide to become a Mistra SafeChem partner?

– Cambrex joined the programme because of our commitment and dedication to the environment and the importance of close collaboration with academia and industry to develop sustainable and improved methodologies. I am looking forward to the collaborations and the science!

What do you expect from the programme?

– Cambrex expects that Mistra SafeChem will support to enable sustainable chemistries for the production of fine chemicals and active pharmaceutical ingredients in the future. The collaboration in the programme combines industry insights and challenges with the latest academic achievements. We will collaborate within the field of catalysis together with Stockholm University and AstraZeneca, which aims to give additional tools for the chemists in preparing complex products.

How does Cambrex intend to contribute to the work?

– We will contribute by participating in case studies within the development of catalytic processes. Our contribution will be to provide industrial insight into the programme together with our expertise in large-scale processes. If we find a successful process, we can support scaling up the process to a larger scale in the laboratory.

AstraZeneca has a bold ambition in sustainability

Magnus Johansson is a Senior Principal Scientist in Medicinal Chemistry, Research, and Early Development Cardiovascular Renal, and Metabolism at AstraZeneca R&D. He also devotes time to educating the next generation of scientists, both at Stockholm University and internally at AstraZeneca.

Why did AstraZeneca decide to become a Mistra SafeChem partner?

– AstraZeneca has a bold ambition in sustainability and wants to contribute to a greener chemical industry with emphasis on our core business - drug development. Safechem brings together an attractive cross-disciplinary team that has the power to contribute to a green transformation in the chemical industry.

What do you expect from the programme?

– We expect high-quality research in an open and sharing environment with a focus on cutting-edge green chemistry/technology, including tools to aid decision making in the areas of sustainability, e.g life cycle assessments and toxicology, including ecotoxicology.

How does your company intend to contribute to the work?

– Our scientists will work alongside industrial and academic partners within the program to generate high-quality science. Additionally, we will invite our academic collaborators to take advantage of our infrastructure through several secondments during phase 2.